Skip to main content
INSULET CORP logo

INSULET CORP — Investor Relations & Filings

Ticker · PODD ISIN · US45784P1012 LEI · 549300TZTYD2PYN92D43 US Manufacturing
Filings indexed 1,381 across all filing types
Latest filing 2025-06-10 Director's Dealing
Country US United States of America
Listing US PODD

About INSULET CORP

https://www.omnipod.com

Insulet Corporation is a medical device company that develops, manufactures, and markets innovative technologies for people with diabetes. The company's core product is the Omnipod® platform, which provides a tubeless and wearable alternative to traditional insulin pumps and multiple daily injections. The flagship product, the Omnipod 5 Automated Insulin Delivery System, is a hybrid closed-loop system that integrates with compatible continuous glucose monitors (CGMs). It utilizes SmartAdjust™ technology to automatically predict glucose levels and adjust insulin delivery to help manage glucose levels. The platform also includes the Omnipod DASH® Insulin Management System. Insulet's products are designed to offer simplicity and freedom for individuals with type 1 and type 2 diabetes who require insulin therapy.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-06-10 English
8-K
Regulatory Filings
2025-06-09 English
Regulatory Filings 2025
Regulatory Filings
2025-06-09 English
SD
Regulatory Filings
2025-05-29 English
8-K
Regulatory Filings
2025-05-28 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.